51 2. DETERMINATION OF THE IPI MEASURE › 2.3. Union interest › 2.3.1. Interest of Union economic operators, Regulation (EU) 2025/1197

In forcesince 19 Jun 2025

The Commission has also assessed the impact of the IPI measure on certain Union importers of medical devices sourcing such products in the PRC, including Union economic operators manufacturing medical devices in the PRC and importing them into the Union, as they could face a reduction in their sales of medical devices originating in the PRC, following the imposition of the IPI measure. In this respect, the Commission has considered the comments of entities that submitted inputs following the public consultation on the possible IPI measure and concluded that the potential negative impact of the IPI measure on such operators would still be limited. First, around 96 % of all Union procurement procedures of medical devices would fall outside the scope of the IPI measure, representing approximately 41 % of the total Union medical devices procurement value. Second, these importers would still be able to sell 50 % of their volume of medical devices imported from the PRC affected by the IPI measure in accordance with Article 8(1), letter (b), of the IPI Regulation. Considering that public procurement for medical devices accounts for 50 % to 70 % of the total Union market for medical devices, it can be estimated that the Union importers concerned would be able to keep more than 80 % of their current import volume from the PRC [The estimation is consistent with the expected reduction of the imports of medical devices originating in the PRC, which represents between EUR 1 billion and EUR 1,2 billion annually (see recital 48) and close to 20 % of the EUR 6,2 billion of total imports of medical devices originating in the PRC registered in 2023.]. Finally, any such potential negative economic effects on importers of medical devices affected by the IPI measure would be offset by the broader Union interests, in particular the general objective to engage with the PRC to open its public procurement market for medical devices in a reciprocal way and to ensure a level playing field for all Union operators in the medical devices sector.